Back to HomeBeta

ICD-10 Coding for Chronic Myelomonocytic Leukemia(C93.10, C93.11, C93.12)

Complete ICD-10-CM coding and documentation guide for Chronic Myelomonocytic Leukemia. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

CMML

Related ICD-10 Code Ranges

Complete code families applicable to Chronic Myelomonocytic Leukemia

C93.1Primary Range

Chronic myelomonocytic leukemia

This range includes all codes related to CMML, covering active, remission, and relapsed states.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C93.10Chronic myelomonocytic leukemia, not having achieved remissionUse when CMML is active and not in remission.
  • Persistent monocytosis ≥1 x 10⁹/L
  • ≥10% monocytes in peripheral blood
  • Dysplasia in one or more myeloid lineages
C93.11Chronic myelomonocytic leukemia, in remissionUse when CMML is documented as in remission.
  • No circulating blasts
  • Bone marrow blasts <5% for ≥4 weeks
C93.12Chronic myelomonocytic leukemia, in relapseUse when CMML is documented as relapsed.
  • Recurrent monocytosis
  • Increased blasts in peripheral blood

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for CMML

Essential facts and insights about Chronic Myelomonocytic Leukemia

The ICD-10 code for Chronic Myelomonocytic Leukemia (CMML) is C93.1, with specific codes for remission and relapse.

Primary ICD-10-CM Codes for cmml

Chronic myelomonocytic leukemia, not having achieved remission
Billable Code

Decision Criteria

clinical Criteria

  • Monocytosis ≥1 x 10⁹/L and ≥10% of WBCs

coding Criteria

  • Do not use MDS codes if CMML criteria are met.

Applicable To

  • Active CMML

Excludes

  • Chronic myeloid leukemia (C92.1-)
  • Myelodysplastic syndromes (D46.-)

Clinical Validation Requirements

  • Persistent monocytosis ≥1 x 10⁹/L
  • ≥10% monocytes in peripheral blood
  • Dysplasia in one or more myeloid lineages

Code-Specific Risks

  • Incorrectly coding as MDS when monocytosis criteria are met.

Coding Notes

  • Ensure documentation of monocytosis and dysplasia to support coding.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Other specified diseases of blood and blood-forming organs

D75.838
Use for clonal cytogenetic abnormalities like trisomy 8.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Myelodysplastic syndrome, unspecified

D46.Z
Use D46.Z only if monocytosis <1 x 10⁹/L and no genetic mutations typical of CMML.

Acute myeloid leukemia

C92.0-
Use C92.0- if blasts ≥20% in blood/marrow.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Chronic Myelomonocytic Leukemia to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C93.10.

Impact

Clinical: Misrepresentation of patient's disease status., Regulatory: Non-compliance with coding guidelines., Financial: Potential for claim denial or reduced reimbursement.

Mitigation Strategy

Ensure remission status is clearly documented., Include blast counts in documentation.

Impact

Reimbursement: Incorrect coding may lead to denied claims or reduced reimbursement., Compliance: Non-compliance with ICD-10 guidelines., Data Quality: Inaccurate clinical data affecting patient records.

Mitigation Strategy

Ensure monocytosis and dysplasia are documented to support CMML coding.

Impact

Lack of documentation for persistent monocytosis can lead to audit issues.

Mitigation Strategy

Ensure monocytosis is documented in all relevant clinical notes.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Chronic Myelomonocytic Leukemia, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Chronic Myelomonocytic Leukemia

Use these documentation templates to ensure complete and accurate documentation for Chronic Myelomonocytic Leukemia. These templates include all required elements for proper coding and billing.

Active CMML with monocytosis

Specialty: Hematology

Required Elements

  • Monocytosis levels
  • Bone marrow findings
  • Genetic mutations
  • Treatment response

Example Documentation

Assessment: CMML-1 confirmed: 8% monocytes (1.2 x 10⁹/L), dysplastic granulopoiesis, ASXL1 mutation present.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Patient has CMML.
Good Documentation Example
CMML-1 confirmed: 8% monocytes (1.2 x 10⁹/L), dysplastic granulopoiesis, ASXL1 mutation present.
Explanation
The good example provides specific clinical details supporting the diagnosis.

Need help with ICD-10 coding for Chronic Myelomonocytic Leukemia? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more